Intec Parent Inc (NTEC) Stock Price, Quote, News and Overview
NASDAQ:NTEC - Nasdaq -
NTEC Quote, Performance and Key Statistics
9.63
-1.37 (-12.48%)
The current stock price of NTEC is 9.63 null. In the past month the price decreased by -27.7%. In the past year, price decreased by -71.32%.
NTEC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About NTEC
Company Profile
Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. The company is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The firm is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson’s disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.
Company Info
Intec Parent Inc
12 Hartom Street, Har Hotzvim
JERUSALEM 777512 IL
CEO: Jeffrey A. Meckler
Employees: 70
Company Website: https://www.intecpharma.com
Phone: 97225864657.0
Intec Parent Inc / NTEC FAQ
What is the stock price of Intec Parent Inc today?
The current stock price of NTEC is 9.63 null. The price decreased by -12.48% in the last trading session.
What is the ticker symbol for Intec Parent Inc stock?
The exchange symbol of Intec Parent Inc is NTEC and it is listed on the Nasdaq exchange.
On which exchange is NTEC stock listed?
NTEC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for Intec Parent Inc stock?
3 analysts have analysed NTEC and the average price target is 53.04 null. This implies a price increase of 450.78% is expected in the next year compared to the current price of 9.63. Check the Intec Parent Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Intec Parent Inc worth?
Intec Parent Inc (NTEC) has a market capitalization of 8.65M null. This makes NTEC a Nano Cap stock.
How many employees does Intec Parent Inc have?
Intec Parent Inc (NTEC) currently has 70 employees.
What are the support and resistance levels for Intec Parent Inc (NTEC) stock?
Intec Parent Inc (NTEC) has a support level at 9.16 and a resistance level at 13.1. Check the full technical report for a detailed analysis of NTEC support and resistance levels.
Should I buy Intec Parent Inc (NTEC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NTEC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NTEC, evaluating the profitability, health, valuation and growth aspects
- Intec Parent Inc (NTEC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Intec Parent Inc (NTEC) Sales and EPS estimates to see what analysts future expectations are.
- Intec Parent Inc (NTEC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Intec Parent Inc (NTEC) Insider and Institutional Ownership to learn about the owners and their transactions.
- Intec Parent Inc (NTEC) Stock Chart to make your own analysis
- Intec Parent Inc (NTEC) Latest news and press-releases to stay up to date.
Does Intec Parent Inc (NTEC) stock pay dividends?
NTEC does not pay a dividend.
What is the Price/Earnings (PE) ratio of Intec Parent Inc (NTEC)?
Intec Parent Inc (NTEC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.44).
NTEC Technical Analysis
NTEC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NTEC. Both the profitability and financial health of NTEC have multiple concerns.
NTEC Financial Highlights
Over the last trailing twelve months NTEC reported a non-GAAP Earnings per Share(EPS) of -3.44. The EPS increased by 80.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -83.12% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
NTEC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 73% to NTEC. The Buy consensus is the average rating of analysts ratings from 3 analysts.